Interplay Between Human Leukocyte Antigen Genes and the Microbial Colonization Process of the Newborn Intestine by Palma, Giada de et al.
 1
 
 
 
Interplay between human leukocyte antigen genes and the microbial 
colonization process of the newborn intestine   5 
De Palma. G.1, Capilla, A2, Nadal, I.1, Nova, E.3, Pozo, T.3, Varea, V.4, Polanco, I.5, 
Castillejo, G.6, López, A.7, Garrote, J.A.8, Calvo C.8, García-Novo M.D9, Cilleruelo, M.L.10, 
Ribes-Koninckx, C.7, Palau, F.2 and Y. Sanz1* 
 
1Ecofisicología Microbiana. Instituto de Agroquímica y Tecnología de Alimentos (CSIC), 10 
Valencia, Spain.  
2Instituto de Biomedicina de Valencia (CSIC). CIBER de Enfermedades Raras (CIBERER), 
Valencia, Spain.  
3Departmento de Metabolismo y Nutrición. Instituto del Frío- ICTAN (CSIC), Madrid. Spain. 
4Gastroenterología, Nutrición y Hepatología Pediátrica. Hospital Universitario Sant Joan de 15 
Deu. Barcelona, Spain. 
5Servicio de Gastroenterologia y Nutrición Pediátrica, Hospital Universitario La Paz, Madrid, 
Spain.  
6Unidad de Gastroenterología Pediátrica,  Hospital Universitario Sant Joan de Reus, 
Tarragona, Spain. 20 
7Servcio de Gastroenterologia Pediátrica, Hospital Universitario La Fe, Valencia, Spain. 
8Unidades de Investigación y Pediatría, Hospital Clínico Universitario, Valladolid, Spain. 
9Unidad de Gastroenterologia, Hospital Universitario Infantil Niño Jesús, Madrid, Spain.  
10Servicio de Pediatría, Hospital Severo Ochoa, Leganés, Madrid 
 25 
 
 
 
 
 30 
 
 
*Corresponding author:  Yolanda Sanz 
Instituto de Agroquímica y Tecnología de Alimentos (CSIC) 
    PO Box 73, 46100 Burjassot, Valencia 35 
    Tel: 34 963900022 
 Fax: 34 963636301 
 E-mail: yolsanz@iata.csic.es  
 
 2
Abstract  
Coeliac disease (CD) development involves genetic (HLA-DQ2/DQ8) and environmental 
factors. Herein, the influence of the HLA-DQ genotype on the gut colonization process of 
breast-fed children was determined. A cohort of 20 newborns, with at least one first-degree 
relative with CD, were classified according to their HLA-DQ genotype into high, 5 
intermediate and low genetic risk groups, showing 24-28%, 7-8% and less than 1% 
probability to develop CD, respectively. Faecal microbiota was analysed at 7 days, 1 and 4 
months of children’s age by fluorescence in situ hybridization. When considering all data, 
Bacteroides-Prevotella group proportions were higher (P<0.05) in the high than in the 
intermediate and low genetic risk groups. Gram-negative bacteria, E. coli, Streptococcus-10 
Lactococcus, E. rectale-C. coccoides, sulphate-reducing bacteria, C. lituseburense and C. 
histolyticum group proportions were also significantly higher (P<0.05) in the high than in the 
low genetic risk group. Correlations between these bacterial groups and the genetic risk were 
also detected (P<0.05). In addition, the number and type of CD relative seemed to influence 
(P<0.050) these bacterial proportions in children at CD risk. At 4 months of age, similar 15 
relationships were established between the high genetic risk to develop CD and the 
proportions of Streptococcus-Lactococcus (P<0.05), E. rectale-C. coccoides (P<0.05), C. 
lituseburense (P<0.05), C. histolyticum (P<0.05), Bacteroides-Prevotella (P<0.10) groups 
and total Gram-negative bacteria (P<0.05). The results suggest a relationship between HLA-
DQ genes and the gut microbial colonization process that could lead to a change in the way 20 
this disorder is investigated.     
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Introduction 
Coeliac disease (CD) is the commonest immune-mediated enteropathy triggered by the 
ingestion of cereal gluten proteins in genetically susceptible individuals. CD is a chronic 
inflammatory disorder of the small intestinal mucosa caused by an abnormal Th1 immune 
response to ingested gluten (Rodrigo, 2006). The typical manifestation of CD is the 5 
malabsorption syndrome with chronic diarrhoea, weight loss, abdominal distension and 
impaired growth (Fasano and Catassi, 2005). CD can develop at any age, but it often 
manifests in early childhood between 6 and 24 months of age after the introduction of gluten 
in the diet (Fasano and Catassi, 2005).  
CD is strongly associated with the human leukocyte antigen (HLA) genes of the major 10 
histocompatibility complex (MHC) genomic region. Approximately 95 % of the patients are 
HLA-DQ2 or HLA-DQ8 positives; however, only a small percentage (20-50%) of those 
bearing high risk HLA haplotypes develop CD (Mearin et al., 2005).  Studies with twins 
showed that in 25% of the cases one twin of the pair did not develop CD, supporting a role 
for environmental factors in the presentation of this disorder (Greco et al., 2002). In 15 
particular, the infant feeding pattern is thought to be involved in CD risk (Branski et al., 
2006). Breast-feeding seems to exert a protective effect against CD development (Branski et 
al., 2006; Ivarsson et al., 2002), which may be related to its influence on the microbial 
colonization process of the newborn intestine (Sanz et al., 2008). The incidence of infections 
in early life, which may trigger a Th1 pro-inflammatory response and disrupt the gut 20 
microbial balance, has also been related to an increased risk of CD development (Ivarsson et 
al., 2003; Stene et al., 2006; Sanz et al., 2008).  
The microbiota rapidly colonizes the gut after birth and this process is influenced by a 
number of factors, including the heredity of the mother, the immediate living environment, 
the feeding practices, microbial infections, and the host’s genetics (Bjorkstén, 2006). The 25 
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early stage of colonization is characterized by the presence of higher levels of facultative 
anaerobes (Enterobacteriaceae, Lactobacillus and Streptococcus) than anaerobic bacteria 
(e.g. Bifidobacterium, Bacteroides, Clostridium and Eubacterium), but these proportions are 
reversed within one week after birth. The Bifidobacterium genus is predominant in breast-fed 
infants, reaching up to 90% of the total faecal microbiota, whereas in formula-fed infants the 5 
microbiota is more heterogeneous (Salminen and Isolauri, 2006). The intestinal microbiota 
plays a pivotal role in the morphology and physiology of the gut, providing the basis for a 
healthy gut (Salminen and Isolauri, 2006).  
The gut microbiota serves several functions including regulation of gut permeability and 
immunity to develop adequate responses to microbial and dietary antigens and avoid 10 
overreactions (Conte et al., 2006; Sanz et al., 2007). It was recently demonstrated that the 
neonatal gut microbiota plays an important role in the development of atopy. In particular, a 
lower ratio of bifidobacteria to clostridia in the gut microbiota at neonatal age was shown to 
precede the development of atopy (Kalliomäki et al., 2001a). A recent study also 
demonstrated that probiotic supplementation to mothers before delivery and to their infants 15 
could prevent atopic disease in children (Kalliomäki et al., 2001b). Differences in the 
composition of the gut microbiota have been detected between healthy controls and CD 
patients recently (Nadal et al., 2007; Sánchez et al., 2008; Collado et al., 2009). Nevertheless, 
the knowledge of the role played by the gut microbiota in CD is limited and there is no 
information of its possible contribution to the disease risk based on prospective studies.  20 
The objective of this preliminary study was to determine whether the gut colonization pattern 
of newborns and breast-fed children could be influenced by the genetic risk to develop CD 
based on their HLA-DQ status, in order to get new insights into the influence of host-microbe 
interactions in this disorder.  
 25 
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Materials and Methods 
Subjects and samplings 
This study included 20 healthy infants with at least one first-degree relative suffering from 
CD. Faecal samples were collected from every subject at 7 days, 1 month and 4 months of 
age and kept immediately at -20ºC until analysed. DNA for HLA-DQ genotyping was also 5 
obtained from oral mucosa cells by scraping the inner side of the children’s cheek with sterile 
swabs (Copan innovation, Sarstedt, Germany) at 4 months of age. Data on clinical and 
dietary history of every subject were recorded including type of delivery, time of gestation, 
weight, size and type of feeding (Table 1). Only subjects under exclusive breast-milk feeding 
practices were included in the study. The study was conducted in accordance with the ethical 10 
rules of the Helsinki Declaration (Hong Kong revision, September 1989), following the EEC 
Good Clinical Practice guidelines (document 111/3976/88 of July 1990) and current Spanish 
law which regulates clinical research in humans (Royal Decree 561/1993 regarding clinical 
trials). The study was approved by the local Ethic Committees and written informed consent 
was obtained from the parents of children included in the study. 15 
 
Analysis of the faecal microbiota by fluorescence in situ hybridization (FISH) and flow 
cytometry (FCM) 
Faecal samples were diluted 1 to 10 in phosphate-buffered saline solution (PBS 130 mM 
sodium chloride, 10 mM sodium phosphate, pH between 7.2 and 7.4) and homogenized in a 20 
Lab Blender 400 stomacher (Seward Medical London, UK) for 5 min. Cells were fixed 
overnight with 4% paraformaldehyde. Then, bacteria were washed twice with PBS and 
bacterial pellets were suspended in 1:1 chilled ethanol-PBS and stored at -80ºC until analyzed 
(Nadal et al., 2007). 
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The universal and group-specific probes used for detection of the main bacterial groups 
colonizing the human gut are shown in Table 2 (MOLBIOL, Berlin, Germany). The group-
specific probes were labelled at the 5’-end with fluorescein isothiocyanate (FITC); showing 
green fluorescence. EUB 338 probe, targeting conserved sequences within the bacterial 
domain, was labelled at the 5’end with the indocyanine dye Cy3 showing red fluorescence, 5 
and was used as positive control of total bacteria (Amann et al., 1990). NON EUB 338 probe 
was labelled with FITC and used as negative control to eliminate the background 
fluorescence (Wallner et al., 1993). Aliquots of 45 µl fixed bacterial samples were incubated 
with 5 µl of each fluorescent probe (50ng/µl) in hybridisation solution (10 mM Tris–HCl, 0.9 
M NaCl, pH 8.0, and 0.1% [w/v] sodium dodecyl sulphate) at appropriate temperature (45-50 10 
ºC) overnight. Hybridization conditions were those described by other authors (Table 2), 
except for E. coli and Staphylococcus, which were detected by hybridisation at 50 ºC, and for 
Lactobacillus, which were detected by hybridisation at 45 ºC. Afterwards, bacterial cells were 
incubated with 500 µl washing solution (10 mM Tris–HCl, 0.9 M NaCl, pH 8.0) at the 
corresponding hybridization temperature for 30 min to remove non specific binding of the 15 
probes. Hybridised cells were finally pelleted by centrifugation (12 000 g for 5 min) and 
suspended in 500 µl of PBS for flow cytometry detection. Bacterial groups were enumerated 
by combining each FITC-labelled group-specific probe with the EUB 338-Cy3 probe, and 
expressed as a ratio of cells hybridising with the FITC-labelled specific probe to cells 
hybridising with the EUB 338-Cy3 probe This proportion was corrected by subtracting the 20 
background fluorescence obtained with the negative control probe NON EUB 338 (Sokol et 
al., 2006; Nadal et al., 2007).  
Flow cytometry detections were performed using an EPICS® XL-MCL flow cytometer 
(Beckman Coulter, Florida, USA) as previously described (Nadal et al., 2007). This 
instrument is equipped with two light scatter detectors that measure forward (FSC) and side 25 
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scatter (SSC) and fluorescence detectors that detect appropriately filtered light at green (FL1, 
525 nm) and red-orange (FL3, 620 nm) wavelengths. The event rate was kept at the lowest 
setting (200-300 events per second) to avoid cell overlap. A total of 15 000 events were 
recorded in a list mode file and analyzed with the System II V.3 software (Beckman Coulter).  
 5 
HLA-DQ Genotyping 
DNA was extracted from oral mucosa cells by scraping the inner side of the children’s cheek 
with sterile swabs (Copan innovation, Sarstedt, Germany). The cotton was cut and incubated 
in DLB buffer (100mM Tris HCL pH 7.4, 10mM EDTA pH 8, 10 mM NaCl per litre of 
distilled water); 10% SDS  and 10 µl proteinase K (20 mg/ml) at 65ºC for 1 h and then, a 10 
standard phenol-chloroform DNA extraction method was carried out. Extracted DNA was 
stored in TE buffer (10ml Tris HCl pH 8, 200 µl EDTA 0.5M pH 8 per litre of distilled 
water) at -20ºC until use for genotyping. The DNA concentration, around 50-100 µg/ml, was 
quantified by using the NanoDrop© Spectrophotometer. Low-resolution HLA-DQB1 typing 
was performed by PCR-SSP (Polymerase Chain Reaction-Sequence Specific Primers) 15 
analysis. Each PCR reaction was performed on about 60–90 ng of extracted DNA, 0·5 U of 
BIOTOOLS DNA polymerase (BIOTOOLS B&M S.A, Spain), 1 × PCR Master Mix (Dynal 
AllSet+TM SSP or Olerup SSPTM) containing nucleotides (200 µmol L−1 each), PCR buffer 
(50 mmol L−1 KCl, 1·5 mmol L−1 MgCl2, 10 mmol L−1 Tris–HCl pH 8·3, 0·001% w/v 
gelatine), 5% glycerol and 100 µg mL−1 cresol red, 0·25 µmol L−1 of each allele- or group-20 
specific primer pair and 0·1 µmol L−1 of internal positive control primer pair matching a 
segment of the human growth hormone gene in a final volume of 10 µL. The PCR program 
was as follows: an initial denaturation step at 94 °C for 2 min, followed by 10 two-
temperature cycles (94 °C for 10 s and 65 °C for 60 s) and finally by 20 three-temperature 
cycles (94 °C for 10 s, 61 °C for 50 s and 72 °C for 30 s). Detection of amplified alleles was 25 
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carried out on a 2% agarose gel after electrophoresis and ethidium bromide staining. 
Although the allele DQB1*02 is determinant to be DQ2, HLA-DQA1 alleles were genotyped 
in a stepwise fashion for a high resolution typing to sharpen the risk classification of each 
individual.  
 5 
Statistical analysis 
Statistical analysis was done using the SPSS 15.0 software (SPSS Inc, Chicago, IL, USA). To 
determine whether the microbiological data could be adequately modelled by a normal 
distribution, Kolmogorov-Smirnov test was run and the distribution of the data resulted non 
normal at 90-99% of confidence. Therefore, microbiological data are expressed as medians of 10 
bacterial proportions with interquartile ranges (IQR) and the differences were determined by 
applying the Mann–Whitney U and Wilcoxon W tests for non-parametric data. The presence 
of correlations between factors was tested by Spearman non parametric correlation 
coefficient. A mixed model analysis was applied to study the effect of the genetic risk on 
bacterial counts, and the interactions among all factors with the time sampling as a repeated 15 
measure. Significant differences were established at P value less than 0.10 and 0.05. 
 
Results 
Subjects and HLA genotypes 
The cohort of 20 newborns included in this study were born at term and they had 20 
uncomplicated perinatal period. They showed a mean gestational age of 39.16 ± 1.52 weeks, 
and a mean weight and size of 3321.94 ± 491.26 g and 49.28 ± 2.02 cm, respectively (Table 
1). Most newborns were naturally delivered (17 out of 20) and all were under exclusive 
breast-milk feeding. This cohort of children was analysed for the HLA class II DQA1 and 
DQB1 genotypes. The children were classified in three main CD risk groups, according to 25 
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their DQ haplotype, loosely based on the criterion of Bourgey et al. (2007) and considering 
the HLA distribution of the Eastern Spanish population (Capilla et al., 2007). The first one 
included those individuals carrying the DQ2 haplotype in both cis (DQA1*0501-DQB1*0201 
in homozygosis) or trans conformation (DQA1*0201-DQB1*0202 with DQA1*0505-
DQB1*0301 in heterozygosis). The second group included those individuals carrying the 5 
DQA1*0501-DQB1*0201 haplotype along with any other haplotype. The third group 
included those individuals with other common genotypes not associated with CD. Of the total 
number of children, 28.6% were in the first group with the highest probability (24-28% of 
developing CD (the high risk group), 33.3% were in the second group with a probability of 7-
8% of developing CD (the intermediate risk group), and 38.1% were in the third group with 10 
less than 1% probability of developing CD (the low risk group). These probabilities are 
theoretical and have been estimated on basis of the genotype of each newborn, without 
considering the genotype of the affected relative.  
 
Microbial colonization process in breast-fed children during the first 4 months of life 15 
The dynamics of the microbial colonization process from 7 days till 4 months of life was 
determined (Table 3). In general, most of the analysed bacterial group proportions tended to 
increase with age. Bacteroides-Prevotella proportions significantly increase from 7 days to 1 
month of age (P=0.017), and sulphate-reducing bacteria proportions increased from 7 days to 
4 months (P=0.009) and from 1 to 4 months (P=0.021). Staphylococcus proportions also 20 
increased from 1 to 4 months of age (P=0.086). Statistically significant correlations were also 
found between age and bacterial counts for sulphate-reducing bacteria (R=0.356, P=0.005) 
and Gram-negative bacteria (R=0.258, P=0.046).  
All microbiological data were also analysed as a function of the genetic risk to develop CD 
(Figure 1). Total bacterial proportions were significantly higher in the high and intermediate 25 
 10
genetic risk group than in the low genetic risk group (P=0.010 and P=0.030, respectively). 
Total Gram-negative bacterial proportions were higher in the high genetic risk group than in 
the intermediate and low genetic risk groups, showing significant differences between the 
high and the low genetic risk groups (P=0.009). In addition, significantly higher proportions 
of Bacteroides-Prevotella group were found in children of the high genetic risk group in 5 
comparison with those of the intermediate and low genetic risk groups (P=0.015 and 
P=0.042, respectively). Similar trends were found for E. coli (P=0.011), Streptococcus-
Lactococcus (P=0.003), E. rectale-C. coccoides (P=0.004), sulphate-reducing bacteria 
(P=0.022), C. lituseburense (P=0.002) and C. histolyticum (P=0.020) groups, showing 
proportions significantly higher in the high than in the low genetic risk group. Significant 10 
correlations were also found between the genetic risk group of the infants and specific 
bacterial group proportions by applying Spearman correlation coefficient (Figure1). Higher 
proportions of total Gram-negative bacteria (R=-0.364, P=0.004), E. coli (R=-0.352, 
P=0.007), Bacteroides-Prevotella (R=-0.265, P=0.046), Staphylococcus (R=-0.294, 
P=0.022), Streptococcus-Lactococcus (R=-0.386, P=0.002), sulphate-reducing bacteria (R=-15 
0.311, P=0.016), E. rectale-C. coccoides (R=-0.379, P=0.003), C. histolyticum (R=-0.317, 
P=0.014) and C. lituseburense (R=-0.358, P=0.005) groups were correlated with increased 
genetic risk (Figure 1).  
When considering the effect of the diseased relatives of the children under study, higher 
proportions of E. coli and C. lituseburense groups were observed when the affected relative 20 
was either the mother or the father than when the affected relative was one siblings (P=0.033 
and P=0.016, respectively). Differences were also observed in bacterial proportions between 
those children, who have one of the parents plus one sibling with CD, and those who only 
have one relative (the mother or the father) with CD. In particular, E. coli (P=0.042), E. 
rectale-C. coccoides (P=0.019), C. lituseburense (P=0.028), Lactobacillus (P=0.040), 25 
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Streptococcus-Lactococcus (P=0.040), Gram-positive bacteria (P=0.019) and total bacteria 
(P=0.028) were higher when the affected relatives were one of the parents together with a 
sibling. Statistically significant correlations were found between the CD relative being the 
mother and increased proportions of E. coli (R=0.275, P=0.048), E. rectale-C. coccoides 
(R=0.304, P=0.025), C. lituseburense (R=0.315, P=0.019), Lactobacillus, Streptococcus-5 
Lactococcus (R=0.272, P=0.047) and Gram positive bacteria (R=0.323, P=0.016).  
When data were adjusted by age, total bacteria (P=0.016), Streptococcus-Lactococcus 
(P=0.010), E. rectale-C. coccoides (P=0.093), C. lituseburense (P=0.015), C. histolyticum 
(P=0.015) and Bacteroides-Prevotella (P=0.100) group proportions were higher in the high 
genetic risk group than in the low genetic risk group at 4 months of age. Similar correlations 10 
were found between higher proportions of these bacterial groups and increased genetic risk of 
CD development (Figure 2). At 7 days and 1 month of age similar trends were found but 
statistical significance was not always reached probably due to the limited number of studied 
cases. Interactions between age, genetic risk and bacterial proportions were not significant. 
 15 
Discussion 
This is the first follow-up study of the intestinal colonization process of the microbiota in 
children at family risk of developing CD. A cohort of first-degree relatives of CD patients 
was analyzed for their HLA class II DQA1 and DQB1 genotype. These two loci are 
transmitted in haplotypes and encode the alpha and beta-chain that forms the DQ 20 
heterodimer, a cell surface receptor of antigen presenting cells involved in gliadin peptide 
presentation in CD patients. In this study, three groups of different genetic risk were defined 
to establish a possible relationship between the HLA-DQ genotype and the gut microbial 
colonization process. This classification was based on the recent stratification of CD risk into 
five classes according to the HLA-DQ genotype in European population, which was 25 
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comparable to the Spanish one (Margaritte-Jeannin et al., 2004 and Bourgey et al., 2007, 
Capilla et al., 2007, Donat et al., 2009). In this work, we have considered the need to change 
the initial five group classification into three main groups given our moderate sample size and 
the absence of patient’s genotype. On the other hand, the DQ8 haplotype (DQA1*0301-
DQB1*0302) was not considered as a coeliac risk haplotype by itself in Spanish population, 5 
as occurs in other European countries. DQ8 haplotype is considered as a risk haplotype only 
in the case that it is transmitted in heterozygosis together with the DQA1*0501-DQB1*0201 
or DQA1*0201-DQB1*0202 haplotypes as well as in homozygosis with itself, so newborns 
carrying this genotype are included in the second risk group.  
Overall, the dynamics of the colonization process of the whole cohort of children showed 10 
similar patterns as those reported in previous studies for general population (Fanaro et al., 
2003; Adlerberth et al., 2007; 2006). In this study, most bacterial populations tended to 
increase with age, particularly the strict anaerobic groups Bacteroides-Prevotella and 
sulphate-reducing bacteria and the facultative group Staphylococcus. In previous reports, 
Bacteroides counts also increased as the colonization process progressed, while levels of 15 
facultative anaerobes dropped within the first week of life (Fanaro et al., 2003). Nevertheless, 
in this study Staphylococcus levels increased in the studied period as reported in other recent 
cohort studies on European and Swedish infants (Adlerberth et al., 2007; 2006). Human milk 
that is considered a continuous source of commensal bacteria to the infant gut, including 
Staphylococcus species, could partly explain the abundance and origin of this bacterial group 20 
in the faeces of the studied babies under breast-feeding practices (Delgado et al., 2008). 
Bifidobacterium genus dominated the microbiota of the studied population over the entire 
period, which is characteristic of breast-fed babies, but its proportions did not increase with 
age in agreement with previous studies after 3 months of life (Fanaro et al., 2003). 
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The study of the effects of the HLA genotype on the colonization process revealed an 
association between higher proportions of Bacteroides-Prevotella group and the high genetic 
risk group, compared with the intermediate and low genetic risk groups. Total Gram-negative 
bacteria, E. coli, Streptococcus-Lactococcus, E. rectale-C. coccoides, C. lituseburense and C. 
histolyticum group proportions followed a similar trend when comparing the high versus the 5 
low genetic risk groups. In addition, higher levels of all these bacterial groups correlated with 
higher genetic risk. An increased number of affected coeliac relatives as well as the mother 
being the affected relative seemed to be associated with higher proportions of bacterial 
groups (E. coli, E. rectale-C. coccoides, C. lituseburense and Streptococcus-Lactococcus) 
related to increased CD risk in children. These results suggest that the features of the affected 10 
relative’s microbiota could partially be transferred to the newborns with higher probability in 
both cases. Similar associations between increased Streptococcus-Lactococcus, E. rectale- C. 
coccoides, C. lituseburense, C. histolyticum and Bacteroides-Prevotella proportions and 
increased genetic risk of CD development were detected at 4 months. These preliminary 
results suggest that HLA class II molecules of the MHC could be a genetic host factor 15 
modulating the gut microbial colonization process and thereby disease risk. In murine 
models, it has been suggested that the MHC is one of the genetic factors exerting a 
pronounced influence on composition of the faecal microbiota using diverse mouse strains 
congenic for MHC (Toivanen et al., 2001). In human subjects, the only evidence of the 
influence of the genetic background in the structure of the intestinal microbiota is based on 20 
comparisons between twins and non-genetic related individuals, showing that subjects with a 
common genetic background had the highest similarities in their gut microbiota (Stewart et 
al., 2005; Palmer et al., 2007; Dicksved et al., 2008). MHC genes are responsible for 
encoding cell-surface antigen-presenting proteins that have a vital role in the immunological 
dialogue that occurs between T cells and other cells involved in autoimmune disorders. Many 25 
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autoimmune conditions have close genetic linkages to particular human HLA class II genes, 
such as CD, type-1 diabetes and rheumatoid arthritis. CD and rheumatoid arthritis have also 
been associated with imbalances in the intestinal microbiota particularly in newly diagnosed 
patients (Nadal et al., 2007; Vaahtovuo et al., 2008; Thompson-Chagoyán et al., 2007; Wen 
et al., 2008). MHC genes together with non-MHC autosomal genes have also been associated 5 
with susceptibility to infectious agents such as Helicobacter felis, Listeria monocytogenes 
and Salmonella enterica serovar Typhimurium (Plant and Glynn, 1976; Gervais et al, 1984; 
Mohammadi et al., 1996). In particular, HLA-DQ genes have been shown to influence the 
host response against Helicobacter pylori and the HLA-DQB1 genotype, which is also 
associated with CD and type-1 diabetes, was related to development of atrophic gastritis in H. 10 
pylori-infected patients (Sakai et al., 1999). In addition, higher incidence of infections, which 
can promote a Th1 protective immune response, has also been associated with increased risk 
of developing CD in early life (Ivarsson et al., 2003, Sanz et al., 2008).  
Although the knowledge of the mechanisms by which MHC and particularly HLA-DQ 
molecules could influence the gut microbiota composition will require further investigations, 15 
these molecules could be involved in immune activation leading to tolerance or elimination 
of the microbe. Intestinal dendritic cells act as sentinels, sampling the mucosal surface for 
dietary or microbial antigens, thereby activating antigen presentation and specific T-cell 
responses that could favour tolerance to specific bacterial groups or facilitate their immune 
elimination modifying their relative proportions (Winkler et al., 2007).  20 
Given that the major source of microbial stimuli in infancy is the gut microbiota, its 
distinctive characteristics in each infant may differently influence host physiology and 
immune responses, leading to either tolerance or a biased Th1 or Th2 cytokine response and 
thereby to disease (Hessle et al., 2000; Kalliomaki et al., 2001a; Adlerberth et al., 2007). The 
development of atopy has been shown to be preceded by deviations in gut microbiota, 25 
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characterized by lower prevalence of Gram-positive anaerobes and a higher ratio of clostridia 
to bifidobacteria at neonatal age (Penders et al., 2007; Kalliomaki et al., 2001a). In addition, 
studies in 1-year-old healthy Swedish and Estonian children, which represent two population 
groups with high and low incidence of CD and allergy, respectively, also showed increased 
levels of Clostridium in Swedish group (Sepp et al., 1997). In addition, Bacteroides and 5 
Clostridium were those groups present in many Swedish infants, while not in Estonian infants 
(Sepp et al., 1997).  
In summary, the obtained results suggest a relationship between the HLA-DQ genes and the 
colonization process of the gut microbiota at early life, which could play a role in the risk to 
develop CD. Further work is in progress to confirm these preliminary observations that could 10 
lead to a significant change in the way autoimmune disorders and their therapies are 
investigated. 
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FIGURE LEGEND 
 
Figure 1. Composition of the faecal microbiota of a cohort of children at family risk of CD 
development as a function of their HLA-DQ genotype, considering all data points. Median 
values of specific-group probe labelled bacteria in relation to total EUB-probe labelled 
bacteria (% Group-specific/EUB) and interquartile ranges (IQR). Correlations between 
bacterial group proportions and the genetic risk (High risk, 24-280% probability; 
Intermediate risk, 7-8% probability; and low risk <1% probability of developing CD) were 
established by the Spearman’s test and significant differences were defined at P < 0.10 or 
0.05.  
 
Figure 2. Composition of the faecal microbiota of a cohort of children at family risk of CD 
development as a function of their HLA-DQ genotype at 4 months of age. Median values of 
specific-group probe labelled bacteria in relation to total EUB-probe labelled bacteria (% 
Group-specific/EUB) and interquartile ranges (IQR). Correlations between bacterial group 
proportions and the genetic risk (High risk, 24-28% probability; Intermediate risk, 7-8% 
probability; and low risk <1% probability of developing CD) were established by the 
Spearman’s test and significant differences were defined at P < 0.10 or 0.05.  
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Table 1. Characteristics of the studied cohort of newborns  
 
 Total subjects (n=20) 
Delivery 
                               vaginal 
  
caesarean 
 
17/20 
 
3/20 
 
Size (cm) 
 
49.28 ± 2.02 
 
Weight (g) 
 
3321.94 ± 491.26 
Weeks of gestation 
 
39.16 ± 1.52 
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Table 2. Oligonucleotide probes and hybridization conditions used in FISH analysis of faecal bacteria 
 
Probe Target bacterial group Sequence (5’-3’) Hybridization conditions References 
Eub 338 All bacteria GCTGCCTCCCGTAGGAGT 50°C Wallner et al. (1993) 
Non EUB 338 Negative control ACTCCTACGGGAGGCAGC 50°C Wallner et al. (1993) 
Bif 164 Bifidobacterium  CATCCGGCATTACCACCC 50ºC Langendijk et al. (1995) 
Bac 303 Bacteroides/Prevotella CCAATGTGGGGGACCTT 46ºC Manz et al. (1996) 
Erec 0482 Eubacterium rectale/ Clostridium coccoides GCTTCTTAGTCARGTACCG 50ºC Franks et al. (1998) 
E.coli 1513 Escherichia coli CACCGTAGTGCCTCGTCATCA 50ºC Poulsen et al. (1994) 
Strc 493 Streptococcus/Lactococcus GTTAGCCGTCCCTTTCTGG 50°C Franks et al. (1998) 
Lab 158 Lactobacillus/other lactic acid bacteria GGTATTAGCA(T/C)CTGTTTCCA 45°C Harmsen et al. (1999) 
Sta  Staphylococcus TCCTCCATATCTCTGCGC 50°C Kempf et al.(2000) 
C. His 150 Clostridium histolyticum TTATGCGGTATTAATCT(C/T)CCTTT 50°C Franks et al. (1998) 
C. Lit 135 Clostridium lituseburense GTTATCCGTGTGTACAGGG 50°C Franks et al. (1998) 
SRB Sulphate reducing bacteria TACGGATTTCACTCCT 50°C Bullock et al. (2004) 
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Table 3. Microbial colonization process in children at family risk of CD development during the first 4 months of life 
 
7 days  
(n=20) 
1 month  
(n=20) 
4 months  
(n=20) 
Mann –Whitney U-test  
P value Bacterial group 
Group-specific bacteria/EUB(%)  (IQR) 7 d-1 month 7d-4 months 1m-4 months 
Lactobacillus group  2.09 (0.80-2.97) 1.77 (1.20-5.34) 2.81 (1.51-8.21) 0.513 0.095 0.231 
Bifidobacterium  9.20 (6.22-12.20) 10.57 (6.20-25.00) 12.21 (4.17-15.43) 0.234 0.301 0.589 
Streptococcus-Lactococcus 2.85 (1.64-6.01) 2.91 (1.54-7.15) 3.07 (2.02-5.04) 0.925 0.841 0.758 
Staphylococcus 1.99 (1.16-6.57) 2.47 (1.24-7.00) 4.71 (2.83-7.60) 0.678 0.086 0.086 
E. rectale-C. coccoides 1.95 (1.30-4.68) 2.30 (1.20-5.38) 2.22 (1.20-6.63) 0.911 0.813 0.989 
E. coli  2.37 (1.36-4.63) 2.25 (1.43-3.49) 3.13 (1.42-5.72) 0.707 0.515 0.380 
Bacteroides-Prevotella  2.58 (1.36-5.33) 6.15 (3.45-8.58) 4.61 (2.32-8.81)  0.017* 0.125 0.407 
C. histolyticum 2.85 (1.44-6.15) 2.47 (1.47-5.43) 2.76 (1.80-5.36) 0.925 0.718 0.620 
C. lituseburense 2.14 (1.05-5.18) 1.97 (1.34-4.98) 1.62 (1.13-4.76) 0.529 0.947 0.512 
Sulphate-reducing bacteria  1.12 (0.76-3.99) 1.47 (1.06-2.93) 3.62 (1.38-10.11) 0.461 0.009* 0.021* 
‡Sum Gram positive  24.72 (18.54-48.17) 37.57 (17.83-62.65) 32.22 (20.82-66.51) 0.547 0.327 0.718 
‡Sum Gram negative  9.04 (5.16-13.46) 11.37 (7.06-17.92) 12.37 (7.33-32.38) 0.114 0.081 0.417 
‡Sum Total  38.12 (24.24-55.96) 51.27 (22.64-75.63) 42.10 (28.77-53.90) 0.383 0.377 0.874 
 
 ‡Total bacteria, Gram-negative bacteria and Gram-positive bacteria were calculated by adding the relative proportions of the corresponding 
groups related to total bacteria (%specific group/EUB), excluding overlapping probes.   
**Significant differences (P<0.050) between mean values of different group proportions by using the Wilcoxon W-test  
